Does drinking a small amount of anti-foam before endoscopy improve the views obtained?

ISRCTN ISRCTN30607490
DOI https://doi.org/10.1186/ISRCTN30607490
Secondary identifying numbers N0436118041
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
10/09/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr B J Rembacken
Scientific

Gastroenterology
Clarendon Wing
Leeds General Infirmary
Leeds
LS1 3EX
United Kingdom

Phone +44 (0)113 243 2799

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesWe will undertake a prospective, double-dummy controlled study to determine:
1. Are the endoscopic views improved significantly with the use of anti-foam pre-medication?
2. Can the endoscopic examination be carried out quicker with the use antifoam pre-medication?
3. Are we able to detect more significant abnormalities with the use of antifoam pre-medication?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Anaesthesia
InterventionAnti-foam before endoscopy vs standard practice.
Intervention typeProcedure/Surgery
Primary outcome measureImproved endoscopic views of gastric mucosa. Patient opinion on the pre-medication drink, duration of the endoscopy as measured from intubation to extubation, the endoscopists views of the areas of the upper digestive tract will be assessed, rating of the amount of mucosa seen without having to resort to washing the area, independent rating of the proportion of mucosa obscured by bubbles or mucus, endoscopic findings.
Secondary outcome measuresNot provided at time of registration
Overall study start date30/06/2002
Completion date30/12/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants200
Key inclusion criteriaAll patients able to give informed consent and referred for upper digestive endoscopy at lower gastrointestinal (LGI).
Key exclusion criteriaVentilated patients, patients with dysphagia or unable to swallow a mouthful of liquid for any reason, patients already included in a separate endoscopy study will not be recruited.
Date of first enrolment30/06/2002
Date of final enrolment30/12/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Gastroenterology
Leeds
LS1 3EX
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Leeds Teaching Hospitals NHS Trust (UK) NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan